Literature DB >> 20360932

KGF Promotes Paracrine Activation of the SCF/c-KIT Axis from Human Keratinocytes to Melanoma Cells.

Francesca Belleudi1, Giorgia Cardinali, Daniela Kovacs, Mauro Picardo, Maria Rosaria Torrisi.   

Abstract

The paracrine networks of the human melanoma microenvironment are able to influence tumor growth and progression. Among the paracrine growth factors involved in skin homeostasis, the KGF/FGF7 secreted by dermal fibroblasts promotes the epidermal proliferation and differentiation as well as the release from keratinocytes of other paracrine mediators. To evaluate the possible role played by KGF in affecting the behavior of different subtypes of melanoma carrying activating mutations or overexpression of the SCF receptor c-KIT, we used human melanoma cell lines, characterized by different expression levels of c-KIT and opposing responsivity to SCF, and HaCaT keratinocytes. Quantitative real-time reverse transcription-polymerase chain reaction assay and ELISA test on KGF-treated keratinocytes showed enhanced expression and secretion of SCF in response to KGF and dependent on functional KGF receptor. Immunofluorescence microscopy and biochemical analysis showed, in one of the selected melanoma cell models, SCF-dependent c-KIT activation induced by stimulation with the culture supernatants collected from KGF-treated keratinocytes. In keratinocyte-melanoma cocultures stained for the Ki67 proliferation marker, incubation with KGF induced enhanced growth not only of the keratinocytes but also of the melanoma cells, which could be blocked by the c-KIT inhibitor imatinib, demonstrating the establishment of a KGF-induced paracrine signaling network owing to the coexpression of biologically active SCF released from keratinocytes and functional c-KIT on melanoma cells.

Entities:  

Year:  2010        PMID: 20360932      PMCID: PMC2847315          DOI: 10.1593/tlo.09196

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  37 in total

1.  Keratinocyte growth factor inhibits cross-linked envelope formation and nucleosomal fragmentation in cultured human keratinocytes.

Authors:  M D Hines; B L Allen-Hoffmann
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

2.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors:  P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

3.  Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family.

Authors:  C Marchese; J Rubin; D Ron; A Faggioni; M R Torrisi; A Messina; L Frati; S A Aaronson
Journal:  J Cell Physiol       Date:  1990-08       Impact factor: 6.384

4.  Keratinocyte growth factor promotes melanosome transfer to keratinocytes.

Authors:  Giorgia Cardinali; Simona Ceccarelli; Daniela Kovacs; Nicaela Aspite; Lavinia Vittoria Lotti; Maria Rosaria Torrisi; Mauro Picardo
Journal:  J Invest Dermatol       Date:  2005-12       Impact factor: 8.551

Review 5.  A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

Authors:  Keiran S M Smalley
Journal:  Int J Cancer       Date:  2003-05-01       Impact factor: 7.396

Review 6.  Normal and oncogenic forms of the receptor tyrosine kinase kit.

Authors:  Johan Lennartsson; Tanya Jelacic; Diana Linnekin; R Shivakrupa
Journal:  Stem Cells       Date:  2005       Impact factor: 6.277

7.  c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.

Authors:  T Otsuka; H Takayama; R Sharp; G Celli; W J LaRochelle; D P Bottaro; N Ellmore; W Vieira; J W Owens; M Anver; G Merlino
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

Review 8.  c-KIT signaling as the driving oncogenic event in sub-groups of melanomas.

Authors:  Keiran S M Smalley; Vernon K Sondak; Jeffrey S Weber
Journal:  Histol Histopathol       Date:  2009-05       Impact factor: 2.303

9.  Inhibitory effect of imatinib on normal progenitor cells in vitro.

Authors:  Kerol Bartolovic; Stefan Balabanov; Ulrike Hartmann; Martina Komor; Andreas M Boehmler; Hans-Jörg Bühring; Robert Möhle; Dieter Hoelzer; Lothar Kanz; Wolf-Karsten Hofmann; Tim H Brümmendorf
Journal:  Blood       Date:  2003-09-11       Impact factor: 22.113

10.  Lack of clinical efficacy of imatinib in metastatic melanoma.

Authors:  S Ugurel; R Hildenbrand; A Zimpfer; P La Rosée; P Paschka; A Sucker; P Keikavoussi; J C Becker; W Rittgen; A Hochhaus; D Schadendorf
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

View more
  4 in total

1.  Unremitting cell proliferation in the secretory phase of eutopic endometriosis: involvement of pAkt and pGSK3β.

Authors:  Yanira Franco-Murillo; José Antonio Miranda-Rodríguez; Erika Rendón-Huerta; Luis F Montaño; Gerardo Velázquez Cornejo; Lucila Poblano Gómez; Francisco Javier Valdez-Morales; Ignacio Gonzalez-Sanchez; Marco Cerbón
Journal:  Reprod Sci       Date:  2014-09-06       Impact factor: 3.060

2.  Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.

Authors:  Caterina Musolino; Alessandro Allegra; Carmen Mannucci; Sabina Russo; Andrea Alonci; Valerio Maisano; Gioacchino Calapai; Sebastiano Gangemi
Journal:  Turk J Haematol       Date:  2015-06       Impact factor: 1.831

3.  Melanoma stimulates the proteolytic activity of HaCaT keratinocytes.

Authors:  Justyna Mazurkiewicz; Aleksandra Simiczyjew; Ewelina Dratkiewicz; Magdalena Kot; Katarzyna Pietraszek-Gremplewicz; Dominika Wilk; Marcin Ziętek; Rafał Matkowski; Dorota Nowak
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

Review 4.  A Systematic Review of Keratinocyte Secretions: A Regenerative Perspective.

Authors:  Ahmed T El-Serafi; Ibrahim El-Serafi; Ingrid Steinvall; Folke Sjöberg; Moustafa Elmasry
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.